Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Long-Term Debt / Capital

Aquestive Therapeutics Inc Long-Term Debt / Capital Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Long-Term Debt / Capital from 2017 to 2018.
  • Aquestive Therapeutics Inc Long-Term Debt / Capital for the quarter ending December 12, 2018 was $74m a -152.81% decrease of -114m year over year
  • Aquestive Therapeutics Inc Long-Term Debt / Capital for the last 12 months ending December 12, 2018 was $74m a -152.81% decrease of -114m year over year
  • Aquestive Therapeutics Inc Annual Long-Term Debt / Capital for 2018 was $74m a -221.84% decrease of -165m from 2017
  • Aquestive Therapeutics Inc Annual Long-Term Debt / Capital for 2017 was $239m a 23.38% increase of 56m from 2016
  • Aquestive Therapeutics Inc Annual Long-Term Debt / Capital for 2016 was $183m a 70.27% increase of 129m from 2015
Other Ratios Metrics:
  • Aquestive Therapeutics Inc Total Debt / Capital for the quarter ending December 12, 2018 was $82m a -136.67% decrease of -113m year over year
  • Aquestive Therapeutics Inc Other Liabilities for the quarter ending December 12, 2018 was $1m a -565.38% decrease of -7m year over year
  • Aquestive Therapeutics Inc Total Debt / Equity for the quarter ending December 12, 2018 was $468m
View Chart On Koyfin

Quarterly AQST Long-Term Debt / Capital Data

12/2018$74m
09/2018$63m
06/2018$606m
03/2018$188m
12/2017$239m

Annual AQST Long-Term Debt / Capital Data

2018$74m
2017$239m
2016$183m
2005$55m